RICHARDSON LINDA M (EVP & Chief Commercial Officer) reported 1 transaction at INTERCEPT PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 1/3/2023ACC: 0001104659-23-000335
Officer· EVP & Chief Commercial Officer
Since Feb 2021
-1.60K
Net shares
Net seller
$19.8K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
1.60K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.60K
Price / share
$12.37
Trade value
$19.79K
% of position
4.8%
12/31/2022
33.08K→31.48K
Total
Net shares
−1.60K
Net value
-$19.79K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/31/2022 | F · Tax Withholding | −1.60K | $12.37 | $19.79K | 4.8% | 33.08K | 31.48K |
| Total | −1.60K | -$19.79K | ||||||
Derivative Transactions0
No derivative transactions reported